Screener
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001860742-26-000088
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of goods sold (excluding amortization and impairments of intangible assets) | 527 | 523 | 1,009 | 1,004 |
| Cost of other revenues | — | 2 | 1 | 3 |
| Selling, general and administrative (Note 4) | 588 | 579 | 1,132 | 1,142 |
| Research and development | 114 | 96 | 215 | 182 |
| Amortization of intangible assets | 57 | 67 | 114 | 134 |
| Other expense, net | 25 | 22 | 51 | 44 |
| 1,311 | 1,289 | 2,522 | 2,509 | |
| Operating income (loss) | 83 | (11) | 116 | (94) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch + Lomb's R&D?
- Bausch + Lomb (BLCO) reported R&D of $114M in Q2 2026.
- How has Bausch + Lomb's R&D changed year-over-year?
- Bausch + Lomb's R&D increased by 18.8% year-over-year, from $96M to $114M.
- What is the long-term trend for Bausch + Lomb's R&D?
- Over 4 years (2021 to 2025), Bausch + Lomb's R&D has grown at a 8.2% compound annual growth rate (CAGR), from $271M to $371M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Bausch + Lomb's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude